Homburger advised H.I.G. Capital on its acquisition of Celerion

On November 3, 2022, H.I.G. Capital, a leading global investment firm with USD 52 bn of equity capital under management, announced that one of its affiliates has completed the acquisition of Celerion Holdings Inc., a leading full-service provider of outsourced clinical research services to the pharmaceutical industry.

The Homburger team comprised partner Andreas Müller, lead associate Sarah Chevalley, associate Oliver Kneubühl and junior associate Michele Fazari (all Corporate / M&A), associates Joel Fink (IP / IT) and Kirsten Wesiak-Schmidt (Data Protection).